UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039242
Receipt number R000044738
Scientific Title Investigation of the relationship between innate immune responses and coagulofibrinolytic responses in patients with out-of-hospital cardiac arrest
Date of disclosure of the study information 2020/01/23
Last modified on 2022/07/29 20:44:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the relationship between immune system and coagulation system in patient with cardiac arrest outside the hospital

Acronym

Investigation of the relationship between immune responses and coagulation responses in patient with cardiac arrest outside the hospital

Scientific Title

Investigation of the relationship between innate immune responses and coagulofibrinolytic responses in patients with out-of-hospital cardiac arrest

Scientific Title:Acronym

Investigation of the relationship between innate immune responses and coagulofibrinolytic responses in patients with out-of-hospital cardiac arrest

Region

Japan


Condition

Condition

Out-of-hospital cardiac arrest

Classification by specialty

Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Danger-associated molecular patterns (DAMPs) such as histones cause the endothelial cell injury and the activation of neutrophil.
DAMPs cause hypercoagulation, dysfunction of anticoagulation system and inhibition of fibrinolysis.
DAMPs produce immunothrombosis depending on activated neutrophils and systemic inflammation causes disseminated intravascular coagulation (DIC).
Cardiac arrest and resuscitation, namely systemic ischemia an reperfusion cause the release of DAMPs.
The development of DIC in patients after cardiac arrest and resuscitation cause organ dysfunction, leading to poor outcome.

Based on the above reports, the purpose of this study is to prove the hypothesis that thrombin, which is produced by histones released after cardiac arrest and resuscitation is associated with the development of DIC, leading organ dysfunction and poor outcome.

Basic objectives2

Others

Basic objectives -Others

Investigation of pathomechanism

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Severity of organ dysfunction, assessed by Sequential Organ Failure Assessment (SOFA) score

Key secondary outcomes

The levels of histone H3, interleukin-6, and various markers of coagulation and fibrinolysis
Outcome (organ dysfunction, 28-days mortality and hospital death)
Impact of DIC on outcome


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are 20 years of age or older at the time of obtaining consent
Patients who died without return of spontaneous circulation after out-of-hospital cardiac arrest
Patients who get return of spontaneous circulation
Investigators have to get informed consent from the patients or their legal authorized representatives after explaining the participation in this study to them and confirming their understanding.

Key exclusion criteria

Patients with cardiac arrest due to trauma, acute aortic dissection or ruptured aortic aneurysm
Patients who take anticoagulants
Patients with coagulofibrinolytic disorders as underlying diseases
Other patients who are judged inappropriate by the principal investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name WADA

Organization

Hokkaido University Hospital

Division name

Department of Emergency Medicine

Zip code

060-8648

Address

Kita-ku, N14W15, Sapporo

TEL

011-706-7377

Email

twada1@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name WADA

Organization

Hokkaido University Hospital

Division name

Department of Emergency Medicine

Zip code

060-8648

Address

Kita-ku, N14W15, Sapporo

TEL

011-706-7377

Homepage URL


Email

twada1@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JP


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Division of Clinical Research Administration, Hokkaido University Hospital

Address

Kita-ku, N14W5, Sapporo

Tel

0117067636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 23 Day


Related information

URL releasing protocol

N/A

Publication of results

Published


Result

URL related to results and publications

https://www.frontiersin.org/articles/10.3389/fcvm.2022.885406/full

Number of participants that the trial has enrolled

62

Results

Patients with MODS exhibited higher histone levels than those without MODS during the early phase of the post-resuscitation period.Severe endothelial injury and higher thrombin and plasmin generation were observed in the MODS group. Plasma levels of histones were positively correlated with those of soluble fibrin immediately after resuscitation and PIC 3 h after arriving at the hospital. This correlation was prominent in the patient population with MODS.

Results date posted

2022 Year 07 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

There were no significant differences in age, sex, or initial rhythm of the electrocardiogram between patients from the two groups. The frequencies of witnessing the onset of cardiac arrest and bystander CPR were comparable between groups. However, the non-MODS group had a significantly higher percentage of patients with cardiogenic cardiac arrests. The CPR duration was significantly longer in the MODS group
than in the non-MODS group. Patients in the MODS group exhibited a higher DIC score on day 1 and a higher APACHE II score than those in the non-MODS group. Furthermore, the hospital survival rate was significantly higher in the non-MODS group than in the MODS group.

Participant flow

Out of the 47 patients, 12 were excluded from the study. Among the excluded patients, 11 did not achieve return of spontaneous circulation. We also excluded one patient because the samples were not treated appropriately.
In the present study, we analyzed the final cohort of 35 patients.
The patients were divided into multiple organ dysfunction (MODS) (n = 15) and non-MODS (n=20) groups.

Adverse events

N/A

Outcome measures

N/A

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 06 Month 04 Day

Date of IRB

2018 Year 06 Month 22 Day

Anticipated trial start date

2018 Year 09 Month 03 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Measurement items
Histone H3, IL6, activated protein C, soluble fibrin, plasmin antiplasmin complex, soluble thrombomodulin, tPA activity, PAI1 activity

Observation items and its implementation methods
Researchers investigate the following items in patient group and use the data for this study. These are all items which are performed in daily clinical practice, and their frequency is equivalent to that in daily clinical practice.

Basic information of the objectives in this study. age, gender, weight, height, body temperature, blood pressure, pulse rate, respiratory rate, urine volume, medical past history, underlying disease, surgery, treatment, and 28 days or hospital outcome
Hematology. Ht, white blood cell counts, platelet counts
Blood biochemical tests. total bilirubin, creatinine, Na, K
Coagulation and fibrinolysis test. PT, fibrinogen, FDP, D dimer
Blood gas test. pH, PaO2, PaCO2, BE, HCO3
Various scores. APACHEII, SOFA, SIRS, DIC


Management information

Registered date

2020 Year 01 Month 23 Day

Last modified on

2022 Year 07 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044738


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name